PECAM1 and diabetes mellitus: At baseline, CD31+/CD41a− EMPs and CD31+/CD41a+ PMPs in group III (patients without DM) were significantly lower than those in group I and group II, but there were no significant differences in CD31+/CD41a− EMPs and PMPs between group I and group II.